Edwards Lifesciences enters into agreement to acquire CASMED for $100 million cash
Edwards Lifesciences announced it has entered into a definitive merger agreement to acquire CAS Medical Systems, a medical technology company dedicated to non-invasive monitoring of tissue oxygenation in the brain. Edwards will acquire CASMED in an all-cash transaction for $2.45 per share. February 12, 2019
